Will be interesting to see how the SP plays out over the next few months. Between now and the end of the year some things that are happening and could happen which will affect the SP i have listed:
1- Landstead funding arrangement ending
2- Orphan drug application(s) (ODA)- FDA aims to process 75% of applications within 120 days of receipt
3- More NNZ-2591 indications announced and potentially more ODA
4- ROW deal(s)
5- P3 Trof commencing + potential for development milestone payment with this
6- Fragile X development plans announced
7- TO
Ann: Chairman's Address at 2019 Annual Meeting of Shareholders, page-24
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.80 |
Change
-0.830(5.31%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $15.65 | $15.72 | $14.76 | $11.61M | 772.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1392 | $14.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.90 | 1553 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |